{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:48:31Z","timestamp":1794300511084,"version":"4.9.0"},"reference-count":33,"publisher":"University of Tokushima Faculty of Medicine","issue":"3.4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2021]]},"DOI":"10.2152\/jmi.68.232","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T22:10:51Z","timestamp":1636582251000},"page":"232-237","source":"Crossref","is-referenced-by-count":13,"title":["RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN"],"prefix":"10.2152","volume":"68","author":[{"given":"Dinda Anes","family":"Tunjungsari","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine Universitas Airlangga\u2009\/\u2009Dr Soetomo General Academic Hospital, Surabaya\u2009-\u2009Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prastiya Indra","family":"Gunawan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine Universitas Airlangga\u2009\/\u2009Dr Soetomo General Academic Hospital, Surabaya\u2009-\u2009Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I Dewa Gede","family":"Ugrasena","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine Universitas Airlangga\u2009\/\u2009Dr Soetomo General Academic Hospital, Surabaya\u2009-\u2009Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Smith EML, Li L, Chiang CW, Thomas K, Hutchinson RJ, Wells EM, Ho RH, Skiles J, Chakraborty A, Bridges CM, Renbarger J\u2005:\u2005Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. J Peripher Nerv System 20\u2005:\u200537-46, 2015","DOI":"10.1111\/jns.12114"},{"key":"2","unstructured":"2. Unit Koordinasi Kerja Hematologi Onkologi Ikatan Dokter Anak Indonesia\u2005:\u2005Protokol Pengobatan Leukemia Limfoblastik Anak. Ikatan Dokter Anak Indonesia, Jakarta, 2013"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Jain P, Gulati S, Seth R, Bakhshi S, Toteja GS, Pandey RM\u2005:\u2005Vincristine-induced Neuropathy in Childhood ALL (Acute Lymphoblastic Leukemia) Survivors\u2005:\u2005Prevalence and Electrophysiological Characteristics. J Child Neurol 29\u2005:\u2005932-7, 2014","DOI":"10.1177\/0883073813491829"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Velde ME, Kaspers GL, Abbink FCH, Wilhelm AJ, Ket JCF, Berg M\u2005:\u2005Vincristine-induced peripheral neuropathy in children with cancer\u2005:\u2005A systematic review. Crit Rev Oncol Hematol 114\u2005:\u2005114-30, 2017","DOI":"10.1016\/j.critrevonc.2017.04.004"},{"key":"5","unstructured":"5. Mitchell C, Hall G, Clarke RT\u2005:\u2005Acute leukaemia in children\u2005:\u2005diagnosis and management\u2005:\u2005BMJ 338\u2005:\u20051491-5, 2009"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cooper SL, Brown PA\u2005:\u2005Treatment of Pediatric Acute Lymphoblastic Leukemia\u2005:\u2005Pediatr Clin N Am 62\u2005:\u200561-73, 2015","DOI":"10.1016\/j.pcl.2014.09.006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med 373\u2005:\u20051541-52, 2015","DOI":"10.1056\/NEJMra1400972"},{"key":"8","unstructured":"8. Conter V, Rizzari C, Sala A, Chiesa R, Citterio M, Biondi A\u2005:\u2005Acute Lymphoblastic Leukemia. Orphanet Encyclopedia 1-13, 2014"},{"key":"9","unstructured":"9. Medical record of RSUD Dr. Soetomo. unpublished. 2018"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hartman A, Bos CV, Stijnen T, Pieters R\u2005:\u2005Decrease in Motor Performance in Children with Cancer Is Independent of the Cumulative Dose of Vincristine. Cancer 106\u2005:\u20051395-401, 2006","DOI":"10.1002\/cncr.21706"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Anghelescu DL, Faughnan LG, Jeha S, Relling MV, Hinds PS, Sandlund JT, Cheng, Pei D, Hankins G, Pauley JL, Pui CH\u2005:\u2005Neuropathic Pain during Treatment for Childhood Acute Lymphoblastic Leukemia. Pediatr Blood Cancer 57\u2005:\u20051147-53, 2011","DOI":"10.1002\/pbc.23039"},{"key":"12","unstructured":"12. McLean TW, Wofford MM\u2005:\u2005The Leukemias. In\u2005:\u2005Kliegman RM, Marcdante KJ, Jenson HB, Behrman RE, eds. Nelson Essentials of Pediatrics. 5th ed. Elsevier Saunders, Philadelphia, 2006, pp.737-40"},{"key":"13","unstructured":"13. Sjarif DR, Nasar SS, Devaera Y, Tanjung CF\u2005:\u2005Asuhan Nutrisi Pediatrik (Pediatric Nutrition Care). Ikatan Dokter Anak Indonesia, Jakarta, 2011"},{"key":"14","unstructured":"14. Lo SF\u2005:\u2005Reference Intervals for Laboratory Tests and Procedures. In\u2005:\u2005Robert M, Kliegman RM, Stanton BF, Geme JWS, eds. Nelson Essentials of Pediatrics. 20th ed. Elsevier Saunders, Philadelphia, 2016, pp.3467"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. McDonald CM\u2005:\u2005Electrodiagnosis In Pediatrics. In\u2005:\u2005Alexander MA, Matthews DJ, Murphy KP, eds. Pediatric Rehabilitation. 5th ed. Demos Medical Publishing, New York, 2015, pp.114-8","DOI":"10.1891\/9781617052255.0006"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Madsen ML, Due H, Ejskjaer N, Jensen P, Madsen JM, Dybkaer K\u2005:\u2005Aspects of Vincristine-induced neuropathy in hematologic malignancies\u2005:\u2005a systematic review. Cancer Chemother Pharmacol 84\u2005:\u2005471-85, 2019","DOI":"10.1007\/s00280-019-03884-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Smolik S, Arland L, Hensley MA, Schissel D, Shepperd B, Thomas K, Rodgers C\u2005:\u2005Assessment Tools for Peripheral Neuropathy in Pediatric Oncology\u2005:\u2005A Systematic Review From the Children\u2019s Oncology Group. J Pediatr Oncol Nurs 35\u2005:\u2005267-75, 2018","DOI":"10.1177\/1043454218762705"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tay CG, Lee VWM, Ong LC, Goh KJ, Ariffin H, Fong CY\u2005:\u2005Vincristine induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer 1-7, 2017","DOI":"10.1002\/pbc.26471"},{"key":"19","unstructured":"19. Herfiana S\u2005:\u2005Dampak Fisiologis Kemoterapi pada Anak dengan Leukemia di Rumah Sakit Umum Daerah Dr. Moewardi (Skripsi). Fakultas Ilmu Kesehatan. Universitas Muhammadiyah. Surakarta, 2017"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Diouf B, Crews KR, Lew G, Pei D, Cheng, Bao J, Zheng JJ, Yang W, Fan Y, Wheeler HE, Wing C, Delaney SM, Komatsu M, Paugh SW, McCorkle JR, Lu X, Winick NJ, Carroll WL, Loh ML, Hunger SP, Devidas M, Pui CH, Dolan E, Relling MV, Evans WE\u2005:\u2005Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. JAMA 313\u2005:\u2005815-23, 2015","DOI":"10.1001\/jama.2015.0894"},{"key":"21","unstructured":"21. Toopchizadeh V, Barzegar M, Rezamand A, Feiz AH\u2005:\u2005Electrophysiological consequences of vincristine contained chemotherapy in children\u2005:\u2005A cohort study. J Pediatr Neurol 7\u2005:\u2005351-6, 2009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Messelink HAM, Weerden TMV, Fock JM, Gidding CE, Vingerhoets HM, Schoemaker MM, Goeken LNH, Bokkerink JPM, Kamps WA\u2005:\u2005Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia. Eur J Paediatr Neurol 4\u2005:\u2005225-33, 2000","DOI":"10.1053\/ejpn.1999.0310"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kumar N\u2005:\u2005Nutritional Neuropathies. Neurol Clin 25\u2005:\u2005209-25, 2007","DOI":"10.1016\/j.ncl.2006.11.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gomber S, Dewan P, Chhonker D\u2005:\u2005Vincristine Induced Neurotoxicity in Cancer Patients. Indian J Pediatr 77\u2005:\u200597-100, 2010","DOI":"10.1007\/s12098-009-0254-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Jain P, Gulati S, Toteja GS, Bakhshi S, Seth R, Pandey RM\u2005:\u2005Serum Alpha Tocopherol, Vitamin B12, and Folate Levels in Childhood Acute Lymphoblastic Leukemia Survivors With and Without Neuropathy. J Child Neurol 1-3, 2014","DOI":"10.1177\/0883073814535495"},{"key":"26","unstructured":"26. Mora E, Smith EML, Donohoe C, Hertz DL\u2005:\u2005Vincristine-induced peripheral neuropathy in pediatric cancer patients. Am J Cancer Res 6\u2005:\u20052416-30, 2016"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Segal I, Rassekh SR, Bond MC, Senger C, Schreiber RA\u2005:\u2005Abnormal liver transaminases and conjugated hyperbilirubinemia at presentation of acute lymphoblastic leukemia. Pediatr Blood Cancer 55\u2005:\u2005434-9, 2010","DOI":"10.1002\/pbc.22549"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Felice MS, Hammermuller E, De DaVila MT, Ciocca ME, Fraquelli LE, Lorusso AM, Sackmann-Muriel F\u2005:\u2005Acute Lymphoblastic Leukemia Presenting as Acute Hepatic Failure in Childhood. J Leuk 38\u2005:\u2005633-7, 2000","DOI":"10.3109\/10428190009059284"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Murakami J, Shimizu Y\u2005:\u2005Hepatic manifestations in hematological disorders. Int J Hepatol 1-13, 2013","DOI":"10.1155\/2013\/484903"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gidding CEM, Koopmans MBP, Uges, Kamps WA, Graaf SSN\u2005:\u2005Vincristine pharmacokinetics after repetitive dosing in children. Cancer Chemother Pharmacol 44\u2005:\u2005203-9, 1999","DOI":"10.1007\/s002800050968"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, Schuetz E\u2005:\u2005Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27\u2005:\u2005383-91, 2001","DOI":"10.1038\/86882"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Desai ZR, den Berg HWV, Bridges JM, Shanks RG\u2005:\u2005Can Severe Vincristine Neurotoxicity be Prevented?. Cancer Chemother Pharmacol 8\u2005:\u2005211-4, 1982","DOI":"10.1007\/BF00255486"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Watkins SM, Griffin JP\u2005:\u2005High Incidence of Vincristine-Induced Neuropathy in Lymphomas. Br Med J 1\u2005:\u2005610-2, 1978","DOI":"10.1136\/bmj.1.6113.610"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/68\/3.4\/68_232\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T04:39:48Z","timestamp":1636778388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/68\/3.4\/68_232\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":33,"journal-issue":{"issue":"3.4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.68.232","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}